| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 AntiCancer, Inc. and 2 Department of Surgery, University of California, San Diego, California
Requests for reprints: Robert M. Hoffman, AntiCancer, Inc., 7917 Ostrow Street, San Diego, CA 92111. Phone: 858-654-2555; Fax: 858-268-4175; E-mail: all{at}anticancer.com.
We report here a modified auxotrophic strain of Salmonella typhimurium that can target and cure breast tumors in orthotopic mouse models. We have previously reported development of a genetically modified strain of S. typhimurium, selected for prostate tumor targeting and therapy in vivo. The strain, termed S. typhimurium A1, selectively grew in prostate tumors in xenograft models causing tumor regression. In contrast, normal tissue was cleared of these bacteria even in immunodeficient athymic mice with no apparent side effects. A1 is auxotrophic (leucine-arginine dependent) but apparently receives sufficient nutritional support only from tumor tissue. The ability to grow in viable tumor tissue may account, in part, for the unique antitumor efficacy of the strain. In the present report, to increase tumor-targeting capability of A1, the strain was reisolated after infection of a human colon tumor growing in nude mice. The tumor-isolated strain, termed A1-R, had increased targeting for tumor cells in vivo as well as in vitro compared with A1. Treatment with A1-R resulted in highly effective tumor targeting, including viable tumor tissue and significant tumor shrinkage in mice with s.c. or orthotopic human breast cancer xerographs. Survival of the treated animals was significantly prolonged. Forty percent of treated mice were cured completely and survived as long as non–tumor-bearing mice. These results suggest that amino acid auxotrophic virulent bacteria, which selectively infect and attack viable tumor tissue, are a promising approach to cancer therapy. (Cancer Res 2006; 66(15): 7647-52)
This article has been cited by other articles:
|
|
 |
|
  C. NAGAKURA, K. HAYASHI, M. ZHAO, K. YAMAUCHI, N. YAMAMOTO, H. TSUCHIYA, K. TOMITA, M. BOUVET, and R. M. HOFFMAN Efficacy of a Genetically-modified Salmonella typhimurium in an Orthotopic Human Pancreatic Cancer in Nude Mice Anticancer Res, June 1, 2009; 29(6): 1873 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Arrach, M. Zhao, S. Porwollik, R. M. Hoffman, and M. McClelland Salmonella Promoters Preferentially Activated Inside Tumors Cancer Res., June 15, 2008; 68(12): 4827 - 4832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Westphal, S. Leschner, J. Jablonska, H. Loessner, and S. Weiss Containment of Tumor-Colonizing Bacteria by Host Neutrophils Cancer Res., April 15, 2008; 68(8): 2952 - 2960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, L. Gao, L. Zhao, B. Guo, K. Ji, Y. Tian, J. Wang, H. Yu, J. Hu, D. V. Kalvakolanu, et al. Intratumoral Delivery and Suppression of Prostate Tumor Growth by Attenuated Salmonella enterica serovar typhimurium Carrying Plasmid-Based Small Interfering RNAs Cancer Res., June 15, 2007; 67(12): 5859 - 5864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhao, J. Geller, H. Ma, M. Yang, S. Penman, and R. M. Hoffman Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer PNAS, June 12, 2007; 104(24): 10170 - 10174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Kasinskas and N. S. Forbes Salmonella typhimurium Lacking Ribose Chemoreceptors Localize in Tumor Quiescence and Induce Apoptosis Cancer Res., April 1, 2007; 67(7): 3201 - 3209. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
